We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Idera Pharmaceuticals | AMEX:IDP | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Idera Pharmaceuticals,
Inc.
|
||
(Name of Issuer)
Common
Stock, par value $0.001 per share
|
||
(Title of Class of Securities)
|
||
45168K108
|
||
(CUSIP
Number)
November
8, 2007
|
||
(Date
of Event which Requires Filing of this Statement)
|
CUSIP
No.
45168K108
|
|||
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Felix
J. Baker
|
||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a)
¨
(b)
x
|
||
3
|
SEC
USE ONLY
|
||
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
-0-
|
|
6
|
SHARED
VOTING POWER
3,560,247
|
||
7
|
SOLE
DISPOSITIVE POWER
-0-
|
||
8
|
SHARED
DISPOSITIVE POWER
3,560,247
|
||
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,560,247
|
||
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
¨
(See
Instructions)
|
||
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
15.5%
|
||
12
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No.
45168K108
|
|||
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Julian
C. Baker
|
||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a)
¨
(b)
x
|
||
3
|
SEC
USE ONLY
|
||
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
-0-
|
|
6
|
SHARED
VOTING POWER
3,560,247
|
||
7
|
SOLE
DISPOSITIVE POWER
-0-
|
||
8
|
SHARED
DISPOSITIVE POWER
3,560,247
|
||
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,560,247
|
||
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
¨
(See
Instructions)
|
||
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
15.5%
|
||
12
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Name
|
Business
Address
|
Felix
J. Baker
|
667
Madison Avenue
New
York, NY 10065
|
Julian
C. Baker
|
667
Madison Avenue
New
York, NY 10065
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or (c), check whether
the person filing is a:
N/A
|
Name
|
Number
of Shares
|
Percent
of Class
Outstanding
|
Baker
Bros. Investments, L.P.
|
110,204
|
0.5%
|
Baker
Bros. Investments II, L.P.
|
99,594
|
0.4%
|
Baker
Biotech Fund I, L.P
|
1,094,693
|
4.8%
|
Baker
Brothers Life Sciences, L.P.
|
2,188,393
|
9.5%
|
14159,
L.P.
|
67,363
|
0.3%
|
|
|
|
Total
|
3,560,247
|
15.5%
|
/s/
Felix J. Baker
|
Felix
J. Baker
|
/s/
Julian C. Baker
|
Julian
C. Baker
|
/s/
Felix J. Baker
|
Felix
J. Baker
|
/s/
Julian C. Baker
|
Julian
C. Baker
|
1 Year Idera Pharmaceutical Chart |
1 Month Idera Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions